These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 30672115)

  • 21. Acute Graft-vs-Host Disease After Liver Transplantation: Experience at a High-volume Liver Transplantation Center in Korea.
    Kang WH; Hwang S; Song GW; Jung DH; Park GC; Ahn CS; Moon DB; Kim KH; Ha TY; Kim WJ; Kim SH; Cho HD; Kwon JH; Jwa EK; Lee SG
    Transplant Proc; 2016 Dec; 48(10):3368-3372. PubMed ID: 27931583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) stem cell transplantation using nonmyeloablative conditioning.
    Ogawa H; Ikegame K; Yoshihara S; Kawakami M; Fujioka T; Masuda T; Taniguchi Y; Hasei H; Kaida K; Inoue T; Kim EH; Kawase I
    Biol Blood Marrow Transplant; 2006 Oct; 12(10):1073-84. PubMed ID: 17084371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Disruption of gut immune system caused by damage of intestinal stem cells and their niche in graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.].
    Hayase E; Teshima T
    Clin Calcium; 2017; 27(6):829-833. PubMed ID: 28536321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lung transplantation complicated by graft-versus-host disease and confounded by incidental transfusion-associated macrochimerism.
    Pavenski K; Kamel-Reid S; Wei C; Cserti-Gazdewich CM
    Transfusion; 2008 Oct; 48(10):2190-6. PubMed ID: 18631170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute graft versus host disease following living donor liver transplantation: first Korean report.
    Cho EH; Suh KS; Yang SH; Lee HW; Cho JY; Cho YB; Yi NJ; Lee KU
    Hepatogastroenterology; 2007; 54(79):2120-2. PubMed ID: 18251173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of pretransplant donor anti-recipient cytotoxic and helper T lymphocyte responses as correlates of acute graft-vs.-host disease and survival after unrelated marrow transplantation.
    Pei J; Martin PJ; Longton G; Masewicz S; Mickelson E; Petersdorf E; Anasetti C; Hansen J
    Biol Blood Marrow Transplant; 1997 Aug; 3(3):142-9. PubMed ID: 9310191
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation.
    Pan H; Zhao K; Wang L; Zheng Y; Zhang G; Mai H; Han Y; Yang L; Guo S
    J Surg Res; 2010 May; 160(2):315-24. PubMed ID: 19524257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Total donor chimerism with bone marrow GVHD after multivisceral transplantation.
    Alcazer V; Eljaafari A; Lebras L; Dubois V; Plesa A; Sobh M; Hot A; Dumortier J; Boillot O; Chambrier C; Michallet M
    Am J Hematol; 2018 Nov; 93(11):E372-E374. PubMed ID: 30113704
    [No Abstract]   [Full Text] [Related]  

  • 30. Recovery from established graft-vs-host disease achieved by bone marrow transplantation from a third-party allogeneic donor.
    Taniguchi Y; Yoshihara S; Hoshida Y; Inoue T; Fujioka T; Ikegame K; Kawakami M; Masuda T; Aozasa K; Kawase I; Ogawa H
    Exp Hematol; 2008 Sep; 36(9):1216-25. PubMed ID: 18599183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bone marrow transplantation in miniature swine. III. Graft-versus-host disease and the effect of T cell depletion of marrow.
    Sakamoto K; Sachs DH; Shimada S; Popitz-Bergez FA; Pennington LR; Pescovitz MD; McDonough MA; MacVittie TJ; Katz SI; Gress RE
    Transplantation; 1988 May; 45(5):869-75. PubMed ID: 3285532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Graft-versus-leukaemia activity associated with CMV-seropositive donor, post-transplant CMV infection, young donor age and chronic graft-versus-host disease in bone marrow allograft recipients. The Nordic Bone Marrow Transplantation Group.
    Jacobsen N; Badsberg JH; Lönnqvist B; Ringdén O; Volin L; Rajantie J; Nikoskelainen J; Keiding N
    Bone Marrow Transplant; 1990 Jun; 5(6):413-8. PubMed ID: 2164434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute graft-versus-host disease in pancreas transplantation: a comparison of two case presentations and a review of the literature.
    Weinstein A; Dexter D; KuKuruga DL; Philosophe B; Hess J; Klassen D
    Transplantation; 2006 Jul; 82(1):127-31. PubMed ID: 16861952
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute GVHD is a strong predictor of full donor CD3+ T cell chimerism after reduced intensity conditioning allogeneic stem cell transplantation.
    El-Cheikh J; Vazquez A; Crocchiolo R; Furst S; Calmels B; Castagna L; Lemarie C; Granata A; Ladaique P; Oudin C; Faucher C; Chabannon C; Blaise D
    Am J Hematol; 2012 Dec; 87(12):1074-8. PubMed ID: 22911907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro analysis of donor bone marrow following monoclonal antibody treatment for the prevention of acute graft versus host disease.
    Kohler PC; Erickson C; Finlay JL; Trigg ME; Edwards B; Hong R; Hank JA; Billing R; Bozdech M; Sondel PM
    Cancer Res; 1986 Oct; 46(10):5413-8. PubMed ID: 3530439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of T cell depletion in radiation bone marrow chimeras. I. Evidence for a donor cell population which increases allogeneic chimerism but which lacks the potential to produce GVHD.
    Sykes M; Sheard M; Sachs DH
    J Immunol; 1988 Oct; 141(7):2282-8. PubMed ID: 3049804
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transfusion-associated graft-versus-host disease in a liver transplant recipient: an unusual presentation and review of the literature.
    O'Brien KL; Pereira SE; Wagner J; Shadman M; Hendrie P; Nelson K; Gernsheimer TB; Price T; Reyes JD; Nester T
    Transfusion; 2013 Jan; 53(1):174-80. PubMed ID: 22563807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Graft-versus-host disease following living donor liver transplantation.
    Soejima Y; Shimada M; Suehiro T; Hiroshige S; Gondo H; Takami A; Yasue S; Maehara Y
    Liver Transpl; 2004 Mar; 10(3):460-4. PubMed ID: 15004778
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune Reconstitution Kinetics following Intentionally Induced Mixed Chimerism by Nonmyeloablative Transplantation.
    Kim N; Lee H; Shin J; Nam YS; Im KI; Lim JY; Lee ES; Kang YN; Park SH; Cho SG
    PLoS One; 2015; 10(5):e0126318. PubMed ID: 25961559
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fatal Graft-Versus-Host Disease Following Adult-To-Adult Living Donor Liver Transplantation From an HLA Nonhomozygous Donor.
    Yu YD; Kim DS; Ha N; Jung SW; Han JH; Kim JY; Park SH; Cho YJ
    Prog Transplant; 2016 Dec; 26(4):394-396. PubMed ID: 27555077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.